ImmunityBio Ownership | Who Owns ImmunityBio?


OverviewForecastRevenueFinancialsChart

ImmunityBio Ownership Summary


ImmunityBio is owned by 9.52% institutional investors, 74.11% insiders, and 16.37% retail investors. Vanguard group is the largest institutional shareholder, holding 2.49% of IBRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.84% of its assets in ImmunityBio shares.

IBRX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockImmunityBio9.52%74.11%16.37%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group17.33M2.49%$44.36M
Blackrock funding, inc. /de13.58M1.95%$34.78M
Blackrock11.42M1.70%$72.19M
State street7.86M1.17%$49.70M
Geode capital management3.84M0.55%$9.83M
Woodline partners lp3.44M0.49%$8.81M
Tang capital management2.81M0.40%$7.20M
Ubs group1.59M0.23%$4.06M
Charles schwab investment management1.28M0.18%$3.27M
Northern trust1.14M0.17%$7.22M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tang capital management2.81M0.48%$7.20M
Accurate wealth management560.00K0.26%$1.36M
Clearwater capital advisors846.42K0.21%$2.17M
Sheets smith wealth management633.98K0.20%$1.62M
Allen inc /ny687.57K0.19%$1.76M
Bell & brown wealth advisors34.40K0.08%$217.41K
Meridian investment counsel96.43K0.07%$246.87K
Wealth effects73.70K0.07%$188.67K
Planning capital management14.76K0.07%$93.27K
Collective family office88.83K0.06%$227.41K

Top Buyers

HolderShares% AssetsChange
Woodline partners lp3.44M0.06%3.00M
Tang capital management2.81M0.48%2.81M
Blackrock funding, inc. /de13.58M0.00%1.73M
Ubs group1.59M0.00%1.18M
Blackrock11.42M0.00%1.05M

Top Sellers

HolderShares% AssetsChange
State street7.86M0.00%-6.32M
Cormorant asset management, lp---3.00M
Ubs asset management americas261.73K0.00%-1.28M
Perceptive advisors---1.22M
Altium capital management lp---1.06M

New Positions

HolderShares% AssetsChangeValue
Tang capital management2.81M0.48%2.81M$7.20M
Group one trading498.43K0.00%498.43K$1.28B
B. riley wealth advisors81.55K0.01%81.55K$515.40K
Raymond james financial67.35K0.00%67.35K$172.43K
Capula management60.10K0.00%60.10K$153.86K

Sold Out

HolderChange
Investors research-15.00
Financial gravity asset management-17.00
Nelson, van denburg & campbell wealth management group-26.00
Corecap advisors-70.00
Central bank & trust-80.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20252204.27%81,251,228-1.72%96.75%1196.25%44-
Dec 31, 2024120-36.84%47,071,266-31.49%66.94%60-27.71%25-40.48%
Sep 30, 2024189-8.25%68,622,14511.64%912.32%85-23.42%41-12.77%
Jun 30, 202420412.09%61,450,416-7.05%95.41%11023.60%4711.90%
Mar 31, 202418221.33%66,112,58815.46%129.85%899.88%4240.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv7.45M0.84%-
Vanguard US Total Market Shares ETF5.72M0.67%1.43M
Vanguard Small Cap Index5.34M0.60%63.21K
iShares Russell 2000 ETF3.87M0.44%1.90K
SPDR® S&P Biotech ETF3.66M0.41%4.73K
Vanguard Small Cap Growth Index Inv2.96M0.34%3.59K
Vanguard Institutional Extnd Mkt Idx Tr2.58M0.29%37.75K
Fidelity Small Cap Index1.44M0.16%-
JPM Thematics Genetic Thrps C2 Acc USD878.86K0.13%-30.90K
iShares Russell 2000 Growth ETF1.03M0.12%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 11, 2023SOON-SHIONG PATRICK See remarksBuy-
Jun 05, 2023BLASZYK MICHAEL D-Buy$132.96K
Jun 05, 2023BLASZYK MICHAEL D-Buy$1.33K
Jun 05, 2023BLASZYK MICHAEL D-Buy$63.73K
Jun 02, 2023Brennan John Owen-Buy$29.00K

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q4--
2024 Q2--
2024 Q1--
2023 Q4--

IBRX Ownership FAQ


Who Owns ImmunityBio?

ImmunityBio shareholders are primarily institutional investors at 9.52%, followed by 74.11% insiders and 16.37% retail investors. The average institutional ownership in ImmunityBio's industry, Biotech Stocks , is 63.96%, which ImmunityBio falls below.

Who owns the most shares of ImmunityBio?

ImmunityBio’s largest shareholders are Vanguard group (17.33M shares, 2.49%), Blackrock funding, inc. /de (13.58M shares, 1.95%), and Blackrock (11.42M shares, 1.70%). Together, they hold 6.14% of ImmunityBio’s total shares outstanding.

Does Blackrock own ImmunityBio?

Yes, BlackRock owns 1.70% of ImmunityBio, totaling 11.42M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 72.19M$. In the last quarter, BlackRock increased its holdings by 1.05M shares, a 10.10% change.

Who is ImmunityBio’s biggest shareholder by percentage of total assets invested?

Tang capital management is ImmunityBio’s biggest shareholder by percentage of total assets invested, with 0.48% of its assets in 2.81M ImmunityBio shares, valued at 7.2M$.

Who is the top mutual fund holder of ImmunityBio shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of ImmunityBio shares, with 0.84% of its total shares outstanding invested in 7.45M ImmunityBio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools